Deprotection Step Patents (Class 536/25.31)
  • Publication number: 20040175726
    Abstract: A hydrocarbyldithiomethyl-modified compound of the Formula:
    Type: Application
    Filed: October 27, 2003
    Publication date: September 9, 2004
    Applicant: Quiatech AB, a Swedish corporation
    Inventor: Marek Kwiatkowski
  • Patent number: 6770436
    Abstract: Radiation-activated catalysts (RACs), autocatalytic reactions, and protective groups are employed to achieve a highly sensitive, high resolution, radiation directed combinatorial synthesis of pattern arrays of diverse polymers. When irradiated, RACs produce catalysts that can react with enhancers, such as those involved in autocatalytic reactions. The autocatalytic reactions produce at least one product that removes protecting groups from synthesis intermediates. This invention has a wide variety of applications and is particularly useful for the solid phase combinatorial synthesis of polymers.
    Type: Grant
    Filed: May 25, 2000
    Date of Patent: August 3, 2004
    Assignee: Affymetrix, Inc.
    Inventors: Jody E. Beecher, Martin J. Goldberg, Glenn H. McGall
  • Patent number: 6762298
    Abstract: The invention provides a method of thermally deprotecting the internucleosidic phosphorus linkage of an oligonucleotide, which method comprises heating a protected oligonucleotide in a fluid medium at a substantially neutral pH, so as to deprotect the oligonucleotide. The present invention further provides a method of synthesizing an oligonucleotide using the thermal deprotection method described above, and novel oligonucleotides and intermediates that incorporate the thermolabile protecting group used in accordance with the present invention.
    Type: Grant
    Filed: February 23, 2001
    Date of Patent: July 13, 2004
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Serge L. Beaucage, Andrzej Wilk, Andrzej Grajkowski
  • Patent number: 6762281
    Abstract: Methods of preparing peptide linked oligomeric compounds are provided. The method is useful for preparing larger scale amounts of peptide linked oligomeric compounds. More particularly, the synthesis of peptide linked oligomeric compounds is performed without the problems of aggregation associated with electrostatic interactions. The present method describes using equimolar amounts of oligomeric compounds and peptide reagents providing for an increase in overall efficiency.
    Type: Grant
    Filed: September 7, 2001
    Date of Patent: July 13, 2004
    Assignee: ISIS Pharmaceuticals, Inc.
    Inventors: Muthiah Manoharan, Andrei P. Guzaev
  • Patent number: 6713622
    Abstract: A set of 4,7-dichlororhodamine compounds useful as fluorescent dyes are disclosed having the structures wherein R1-R6 are hydrogen, fluorine, chlorine, lower alkyl, lower alkene, lower alkyne, sulfonate, sulfone, amino, amido, nitrile, lower alkoxy, linking group, or, when taken together, R1 and R6 is benzo, or, when taken together, R4 and R5 is benzo; R7-R10, R12-R16 and R18 may be hydrogen, fluorine, chlorine, lower alkyl, lower alkene, lower alkyne, sulfonate, sulfone, amino, amido, nitrile, lower alkoxy, linking group; R11 and R17 may be hydrogen, lower alkyl, lower alkene, lower alkyne, phenyl, aryl, linking group; Y1-Y4 are hydrogen, lower alkyl, or cycloalkyl, or, when taken together, Y1 and R2, Y2 and R1 Y3 and R3, and/or Y4 and R4 is propano, ethano, or substituted forms thereof, and X1-X3 taken separately are hydrogen, chlorine, fluorine, lower alkyl, carboxylate, sulfonate, hydroxymethyl, and linking group, or any combinations thereof In another aspect, the invention includes reag
    Type: Grant
    Filed: May 25, 2000
    Date of Patent: March 30, 2004
    Assignee: Applera Corporation
    Inventor: Ronald J. Graham
  • Patent number: 6673918
    Abstract: Method for one-pot deprotection of RNA molecules.
    Type: Grant
    Filed: September 21, 2001
    Date of Patent: January 6, 2004
    Assignee: Sirna Therapeutics, Inc.
    Inventors: Laurent Bellon, Christopher T. Workman
  • Patent number: 6664388
    Abstract: The present invention provides a process for the removal of protecting groups, i.e. deprotection, from chemically synthesized oligonucleotides. In one embodiment, the invention provides reagents suitable for use in such a process, and kits incorporating such reagents in a convenient, ready-to-use format. By use of the process and reagents of the invention, side-reactions leading to certain impurities that contaminate the synthesized oligonucleotides can be minimized. Methods and reagents are provided for deprotection of an oligonucleotide by reacting a protected oligonucleotide with a deprotection reagent wherein the deprotection reagent comprises an active methylene compound and an amine reagent. The active methylene compound has the structure: where substituent EWG is an electron-withdrawing group and R is hydrogen, C1-C12 alkyl, C6-C20 aryl, heterocycle or an electron-withdrawing group.
    Type: Grant
    Filed: March 4, 2002
    Date of Patent: December 16, 2003
    Assignee: Applera Corporation
    Inventor: Jeffrey S. Nelson
  • Patent number: 6653458
    Abstract: Modified oligonucleotides containing at least one 2′,5′-internucleotide linkage are provided. The oligonucleotides of the invention may also bear additional substituents at the 2′- and 3′-positions.
    Type: Grant
    Filed: November 8, 1999
    Date of Patent: November 25, 2003
    Assignee: ISIS Pharmaceuticals, Inc.
    Inventors: Muthiah Manoharan, Phillip Dan Cook, Charles J. Guinosso
  • Patent number: 6653468
    Abstract: Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.
    Type: Grant
    Filed: September 30, 2002
    Date of Patent: November 25, 2003
    Assignee: ISIS Pharmaceuticals, Inc.
    Inventors: Andrei P. Guzaev, Muthiah Manoharan
  • Patent number: 6649348
    Abstract: Apparatus and methods are disclosed for synthesizing a plurality of compounds on the surface of supports. Biopolymer features are attached to the surfaces of the supports. The synthesis generally comprises a plurality of steps. In the present invention at least two of the steps are performed by placing a support having a functionalized surface into a chamber of a flow cell and subjecting the surface to a step of the synthesis and placing the support into a chamber of another flow cell and subjecting the surface to another step of the synthesis. An apparatus generally comprises a plurality of flow cells and one or more fluid dispensing stations are mounted on the platform and are in fluid communication with one or more of the plurality of flow cells. A station for monomer addition to the surface of the support is mounted on the platform. The apparatus further comprises a mechanism for moving a support to and from the station for monomer addition and a flow cell and from one flow cell to another flow cell.
    Type: Grant
    Filed: June 29, 2001
    Date of Patent: November 18, 2003
    Assignee: Agilent Technologies Inc.
    Inventors: Jay K. Bass, John F. McEntee, Tim J. Lazaruk, Maryam Mobed-Miremadi
  • Patent number: 6649750
    Abstract: Synthetic processes are provided wherein high purity oligomers are prepared using support bound phosphoramidite protocols starting with a nucleoside or larger synthon linked to a support media through a nucleosidic heterocyclic base moiety. Intermediates undergoing depurination at the support linkage site are removed during the wash cycle. Also provided are compositions useful in such processes.
    Type: Grant
    Filed: January 5, 2000
    Date of Patent: November 18, 2003
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Daniel C. Capaldi, Vasulinga T. Ravikumar, Douglas L. Cole
  • Patent number: 6649751
    Abstract: Provided is a method for purification and synthesis of RNA molecules that have at least one chemical modification.
    Type: Grant
    Filed: May 28, 2002
    Date of Patent: November 18, 2003
    Assignee: Sirna Therapeutics, Inc.
    Inventors: Nassim Usman, Francine Wincott, David Sweedler, Leonid Beigelman, Lech W. Dudycz, Susan Grimm, Anthony DiRenzo, Danuta Tracz
  • Patent number: 6646118
    Abstract: The present invention relates to a support system for solid phase synthesis of oligomers, such as oligonucleotides, wherein the starting compound is bound to the support via a disiloxyl linkage. Furthermore, the invention relates to a method for synthesis of oligonucleotides on a solid support. The support system comprises a stable disiloxyl linkage providing high nucleoside loadings to the support and the method allows convenient non-laborious oligomer synthesis.
    Type: Grant
    Filed: March 25, 2002
    Date of Patent: November 11, 2003
    Assignee: Quiatech AB
    Inventors: Marek Kwiatkowski, Mats Nilsson, Ulf Landegren
  • Patent number: 6632938
    Abstract: Methods for preparing purified oligonucleotides by treating a solution comprising an oligonucleotide with an aggregating agent and a precipitation enhancer under conditions sufficient to form an oligonucleotide aggregate and isolating the oligonucleotide aggregate to produce a purified oligonucleotide.
    Type: Grant
    Filed: June 7, 2001
    Date of Patent: October 14, 2003
    Assignee: ISIS Pharmaceuticals, Inc.
    Inventors: Max N. Moore, John Charles Arthur, Kent Vansooy, Anthony N. Scozzari
  • Patent number: 6630581
    Abstract: The invention provides a method for synthesizing oligonucleotides using carbonate protection of hydroxyl groups and nucleophilic deprotection reagents. The deprotection reagents irreversibly cleave the carbonate protecting groups while simultaneously oxidizing the internucleotide phosphite triester linkage, and can be used in aqueous solution at neutral to mildly basic pH. The method eliminates the need for separate deprotection and oxidation steps, and, since the use of acid to remove protecting groups is unnecessary, acid-induced depurination is avoided. Fluorescent or other readily detectable carbonate protecting groups can be used, enabling monitoring of individual reaction steps during oligonucleotide synthesis. The invention is particularly useful in the highly parallel, microscale synthesis of oligonucleotides. Reagents and kits for carrying out the aforementioned method are provided as well.
    Type: Grant
    Filed: January 8, 2001
    Date of Patent: October 7, 2003
    Assignee: Agilent Technologies, Inc.
    Inventors: Douglas J. Dellinger, Marvin H. Caruthers, Jason R. Betley
  • Publication number: 20030181712
    Abstract: The present invention provides a process for the removal of protecting groups, i.e. deprotection, from chemically synthesized oligonucleotides. In one embodiment, the invention provides reagents suitable for use in such a process, and kits incorporating such reagents in a convenient, ready-to-use format. By use of the process and reagents of the invention, side-reactions leading to certain impurities that contaminate the synthesized oligonucleotides can be minimized.
    Type: Application
    Filed: March 4, 2002
    Publication date: September 25, 2003
    Applicant: PE Corporation (NY)
    Inventor: Jeffrey S. Nelson
  • Publication number: 20030166917
    Abstract: Method for purification and synthesis of RNA molecules and enzymatic RNA molecules in enzymatically active form.
    Type: Application
    Filed: May 28, 2002
    Publication date: September 4, 2003
    Inventors: Nassim Usman, Francine Wincott, David Sweedler, Leonid Beigelman, Lech W. Dudycz, Susan Grimm, Anthony DiRenzo, Danuta Tracz
  • Patent number: 6610842
    Abstract: Synthetic processes are provided wherein oligomers are prepared using phosphoramidite compositions. Oligomers having phosphodiester, phosphorothioate, phosphorodithioate covalent linkages are prepared that can include other covalent linkages. Also provided are compositions useful in such processes.
    Type: Grant
    Filed: May 6, 1999
    Date of Patent: August 26, 2003
    Assignee: ISIS Pharmaceuticals, Inc.
    Inventors: Vasulinga T. Ravikumar, Daniel C. Capaldi, Douglas L. Cole
  • Patent number: 6593464
    Abstract: The invention relates to a process for deblocking substantially a blocked, detectably labeled oligonucleotide by contacting the blocked detectably labeled oligonucleotide with an effective amount of a nucleophilic amino compound under conditions that result in substantial deblocking of the oligonucleotide, thereby giving the substantially deblocked oligonucleotide.
    Type: Grant
    Filed: May 24, 2000
    Date of Patent: July 15, 2003
    Assignee: Invitrogen Corporation
    Inventors: Gulilat Gebeyehu, Richard M. Pires
  • Publication number: 20030113769
    Abstract: The present invention provides oligomers which are specifically hybridizable with a selected sequence of RNA or DNA wherein at least one of the nucleoside moieties of the oligomer is modified to include an aminooxy linkage. These oligomers are useful for diagnostic, therapeutic and investigative purposes.
    Type: Application
    Filed: September 3, 2002
    Publication date: June 19, 2003
    Inventors: Muthiah Manoharan, Harri Lonnberg, Harri Salo, Pasi Virta
  • Patent number: 6576752
    Abstract: The present invention provides oligomers which are specifically hybridizable with a selected sequence of RNA or DNA wherein at least one of the nucleoside moieties of the oligomer is modified to include an aminooxy linkage. These oligomers are useful for diagnostic, therapeutic and investigative purposes.
    Type: Grant
    Filed: June 25, 1999
    Date of Patent: June 10, 2003
    Assignee: ISIS Pharmaceuticals, Inc.
    Inventors: Muthiah Manoharan, Harri Lonnberg, Harri Salo, Pasi Virta
  • Patent number: 6576426
    Abstract: This invention provides reagents, libraries and sets of the reagents, and assay methods using the reagents, the reagents comprising an analyte moiety and a tag moiety, wherein the tag moiety contains information defining the identify and location of the analyte residues of the analyte moiety which is detectable by mass spectrometry.
    Type: Grant
    Filed: December 6, 2001
    Date of Patent: June 10, 2003
    Assignee: Oxford Gene Technology Limited
    Inventors: Edwin Southern, William Jonathan Cummins
  • Patent number: 6566495
    Abstract: A synthetic strategy for the creation of large scale chemical diversity. Solid-phase chemistry, photolabile protecting groups, and photolithography are used to achieve light-directed spatially-addressable parallel chemical synthesis. Binary masking techniques are utilized in one embodiment. A reactor system, photoremovable protective groups, and improved data collection and handling techniques are also disclosed. A technique for screening linker molecules is also provided.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: May 20, 2003
    Assignee: Affymetrix, Inc.
    Inventors: Stephen P. A. Fodor, Lubert Stryer, J. Leighton Read, Michael C. Pirrung
  • Patent number: 6566515
    Abstract: Novel compounds are provided which are useful as linking groups in chemical synthesis, preferably in the solid phase synthesis of oligonucleotides and polypeptides. These compounds are generally photolabile and comprise protecting groups which can be removed by photolysis to unmask a reactive group. The protecting group has the general formula Ar—C(R1)(R2)—O—C(O)— wherein: Ar is an optionally substituted fused polycyclic aryl or heteroaromatic group or a vinylogous derivative thereof; R1 and R2 are independently H, optionally substituted alkyl, alkenyl or alkynyl, optionally substituted aryl or optionally substituted heteroaromatic, or a vinylogous derivative of the foregoing; and X is a leaving group, a chemical fragment linked to Ar—C(R1)(R2)—O—C(O)— via a heteroatom, or a solid support; provided that when Ar is 1-pyrenyl and R1 and R2 are H, X is not linked to Ar—C(R1)(R2)—O—C(O)— via a nitrogen atom.
    Type: Grant
    Filed: March 14, 2000
    Date of Patent: May 20, 2003
    Assignee: Affymetrix, Inc.
    Inventors: Glenn H. McGall, Ngo Q. Nam, Richard P. Rava
  • Patent number: 6559279
    Abstract: Methods of preparing peptide linked oligomeric compounds are provided. The method is useful for preparing larger scale amounts of peptide linked oligomeric compounds. More particularly, the synthesis of peptide linked oligomeric compounds is performed without the problems of aggregation associated with electrostatic interactions. The present method describes using equimolar amounts of oligomeric compounds and peptide reagents providing for an increase in overall efficiency.
    Type: Grant
    Filed: September 8, 2000
    Date of Patent: May 6, 2003
    Assignee: ISIS Pharmaceuticals, Inc.
    Inventors: Muthiah Manoharan, Andrei P. Guzaev
  • Patent number: 6538128
    Abstract: The invention provides improved processes for oligonucleotide synthesis utilizing arenes as solvents for detritylation of oligonucleotides.
    Type: Grant
    Filed: March 22, 1999
    Date of Patent: March 25, 2003
    Assignee: Avecia Biotechnology, Inc.
    Inventors: Guangrong Zhang, Jin-Yan Tang
  • Patent number: 6531584
    Abstract: Compositions and methods are provided for the treatment and diagnosis of diseases amenable to modulation of the production of selected proteins. In accordance with preferred embodiments, oligonucleotides and oligonucleotide analogs are provided which are specifically hybridizable with a selected sequence of RNA or DNA wherein at least one of the 2′-deoxyfuranosyl moieties of the nucleoside unit is modified. Treatment of diseases caused by various viruses and other causative agents is provided.
    Type: Grant
    Filed: September 2, 1999
    Date of Patent: March 11, 2003
    Assignee: ISIS Pharmaceuticals, Inc.
    Inventors: Phillip Dan Cook, Andrew Mamoru Kawasaki
  • Patent number: 6531589
    Abstract: The invention provides new methods for synthesizing oligonucleotides that allow for deprotection of the oligonucleotides under more mild conditions than existing methods. The invention further provides a nucleoside base protecting group that is stable under oligonucleotide synthesis conditions, but which can be removed under more mild conditions than existing protecting groups, as well as nucleoside synthons having such base protecting groups.
    Type: Grant
    Filed: February 8, 1996
    Date of Patent: March 11, 2003
    Assignee: Hybridon, Inc.
    Inventors: Radhakrishnan P. Iyer, Theresa Devlin, Ivan Habus, Dong Yu, Sudhir Agrawal, Nan-Hui Ho
  • Patent number: 6512107
    Abstract: The present invention relates to a novel and improved process for preparing 2′-fluoro-5-methyl-&bgr;-L-arabinofuranosyluridine represented by formula (I) which shows anti-viral activity, especially potent anti-viral activity against hepatitis B-virus and Epstein-Barr virus:
    Type: Grant
    Filed: July 23, 1998
    Date of Patent: January 28, 2003
    Assignee: The University of Georgia Research Foundation
    Inventors: Chung K. Chu, Jinfa Du, Yongseok Choi
  • Patent number: 6509459
    Abstract: The invention provides new processes for synthesizing oligonucleotides that allow for deprotection of the oligonucleotide under more rapid and/or more mild conditions than existing methods. The invention further provides a nucleoside base protecting group that is stable under oligonucleotide synthesis conditions, but which can be removed under more mild conditions than existing protecting groups, as well as nucleoside synthons having such base protecting groups. The invention also provides oligonucleotides containing any of a variety of base labile functionalities and methods for using such oligonucleotides.
    Type: Grant
    Filed: April 30, 1997
    Date of Patent: January 21, 2003
    Assignee: Hybridon, Inc.
    Inventors: Sudhir Agrawal, Radhakrishnan P. Iyer, Ivan Habus, Dong Yu
  • Patent number: 6506895
    Abstract: A photoactivatable nucleic acid derivative composition in which one or more photoreactive group(s) are bound to a natural or synthetic nucleic acid. The photoreactive groups can be bound to the nucleic acid before, during or after its formation, and can thereafter be activated in order to attach the nucleic acid to another molecule, e.g., to the surface of a solid support. Also described is a method of preparing such a composition, and a method of using such a composition to attach the nucleic acid to a another molecule, such as that provided by the surface of a substrate used to prepare a nucleic acid chip by photolithographic techniques.
    Type: Grant
    Filed: February 24, 1998
    Date of Patent: January 14, 2003
    Assignee: SurModics, Inc.
    Inventors: Patrick E. Guire, Melvin J. Swanson, Gary W. Opperman
  • Patent number: 6495676
    Abstract: Methods and compositions are provided for detecting nucleic acid sequences. Probes comprising a crosslinking agent are combined with a sample which may comprise a target sequence which is complementary to the probe. Hybridization is allowed to occur between complementary sequences. The crosslinking agent is activated. Covalent bonds are formed between the probe and the target sequence if they are hybridized to one another. The crosslinked nucleic acids can then be detected to indicate the presence of the target sequence. Also provided are kits comprising reagents.
    Type: Grant
    Filed: September 3, 1999
    Date of Patent: December 17, 2002
    Assignee: Naxcor
    Inventors: Michael L. Wood, David Albagli, Reuel B. Van Atta, Douglas Y. Thien, Peter C. Cheng, Bingfang Huan
  • Patent number: 6489466
    Abstract: Immobilized nucleotide primers of this invention include a modified nucleotide tethered to a support substrate through a linking group. In particular, the modified nucleotide is constructed such that the C-5′ end of the nucleotide is tetherable to the linking group and the protected C-3′ end is available for further controlled modification, e.g., addition of other nucleotides in specific sequences to the immobilized nucleotide primer. Additionally, the linking group is of sufficient length to allow the immobilized nucleotide primer to be used to synthesize and screen arrays of oligonucleotides, e.g., enzymatic C-3′ primer extension.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: December 3, 2002
    Assignee: Linden Technologies, Inc.
    Inventors: Yih Huang, Tai-Nang Huang, Ming Shen
  • Patent number: 6479262
    Abstract: The present invention provides methods of preparing large polynucleotides of arbitrary sequence and in a manner that will readily lend itself to automation. The present invention provides methods of preparing a polynucleotide having at least 200 nucleotides in either a 5′ to 3′ or 3′ to 5′ direction by ligating a plurality of oligonucleotides, the assembly of which, represents the nucleotide sequence of the desired polynucleotide.
    Type: Grant
    Filed: May 16, 2000
    Date of Patent: November 12, 2002
    Assignee: Hercules, Incorporated
    Inventor: Simon Delagrave
  • Publication number: 20020156268
    Abstract: The present invention discloses improved methods for oligonucleotide synthesis and purification. In the methods of the invention, a half-life is determined for deprotection of the 5′-OH protecting group at the 5′-terminus of an oligonucleotide post-synthesis. The half-life is used to determine an optimal reaction time for removal of the 5′-OH protecting group. The methods of the invention are amenable to the large-scale synthesis and purification of oligonucleotides.
    Type: Application
    Filed: March 22, 2002
    Publication date: October 24, 2002
    Inventors: Achim H. Krotz, Bethany M. McElroy, Anthony N. Scozzari
  • Patent number: 6468740
    Abstract: A synthetic strategy for the creation of large scale chemical diversity. Solid-phase chemistry, photolabile protecting groups, and photolithography are used to achieve light-directed spatially-addressable parallel chemical synthesis. In one particular embodiment, an array of rotated cyclic polymers is formed. In another embodiment, an array of polymers is formed based on a target polymer. The array includes systematically substituted versions of the target molecule. In another embodiment, rotated and systematically substituted cyclic polymers are formed on a substrate.
    Type: Grant
    Filed: April 8, 1998
    Date of Patent: October 22, 2002
    Assignee: Affymetrix, Inc.
    Inventor: Christopher P. Holmes
  • Publication number: 20020150937
    Abstract: Disclosed are methods and compositions for extracting nucleic acids from a biological sample. In particular, disclosed is a nucleic acid extraction solution together with methods using such a solution for extracting nucleic acid sequences from biological samples containing cells, cellular debris or both. The nucleic acid extraction solution contains a molecule having the formula R1O—CH2—CH2—OR2, wherein R1 and R2 independently are selected from the group consisting of hydrogen and an alkyl group.
    Type: Application
    Filed: January 15, 2002
    Publication date: October 17, 2002
    Inventors: Brian Lentrichia, Menashi A. Cohenford
  • Patent number: 6465628
    Abstract: Synthetic processes are provided wherein oligomeric compounds are prepared having phosphodiester, phosphorothioate, phosphorodithioate, or other covalent linkages. The oligomers have substantially reduced exocyclic adducts deriving from acrylonitrile or related contaminants.
    Type: Grant
    Filed: April 9, 1999
    Date of Patent: October 15, 2002
    Assignee: ISIS Pharmaceuticals, Inc.
    Inventors: Vasulinga T. Ravikumar, Muthiah Manoharan, Daniel C. Capaldi, Achim Krotz, Douglas L. Cole, Andrei Guzaev
  • Patent number: 6451998
    Abstract: A method of capping a hydroxy group of a moiety, comprising coupling the moiety to a phosphor or phosphite derivative of a protected alcohol, so as to form the corresponding phosphate or phosphite between the hydroxy and phosphor or phosphite groups. The hydroxy group may be later de-capped by hydrolyzing the resulting compound to deprotect the protected alcohol and cleave the phosphate from the moiety so as to regenerate the hydroxy group of the moiety. The method has particular application to fabrication of addressable polynucleotide arrays and allows failed sequences, as well as inter-feature regions, to be left with a free hydroxy group at the ends of the molecules (failed sequences or linkers) at such locations.
    Type: Grant
    Filed: October 18, 1999
    Date of Patent: September 17, 2002
    Assignee: Agilent Technologies, Inc.
    Inventor: Michael G. M. Perbost
  • Publication number: 20020120128
    Abstract: In a process and a device for the parallel preparation of at least 4n oligonucleotides, at least four inserts each with n reaction vessels are first arranged on a plate (16), each reaction vessel containing a nucleotide initiator base bound to an inert carrier. Particular operations are then carried out in parallel with one another at four stations (28, 30, 32, 34), and in particular a deblocking operation simultaneously in all n reaction vessels of the insert at the first station (28), a first washing operation simultaneously in all n reaction vessels of the insert at the second station (30), a coupling operation in all n reaction vessels of the insert at the third station (32), and, simultaneously in all n reaction vessels of the insert at the fourth station (34), a second washing operation followed by a capping operation followed by a third washing operation followed by an oxidation operation followed by a fourth washing operation.
    Type: Application
    Filed: October 26, 2001
    Publication date: August 29, 2002
    Applicant: METABION Gesellschaft fur angewandte Biotechnologie mbH
    Inventor: Ludwig Stockl
  • Patent number: 6441150
    Abstract: This invention presents novel methods for recovery of phosphoramidites from the waste products of oligonucleotide synthesis. The methods include reacting a tribromophenoxydichlorophosphorane with an H-phosphonate in the presence of an amine.
    Type: Grant
    Filed: August 23, 1999
    Date of Patent: August 27, 2002
    Assignee: ISIS Pharmaceuticals, Inc.
    Inventors: Richard H. Griffey, Douglas L. Cole, Vasulinga Ravikumar
  • Patent number: 6429309
    Abstract: The present invention relates to a support system for the solid phase synthesis of oligomers, such as oligonucleotide, wherein the starting compound is bound to the support via a disiloxyl linkage. Furthermore, the invention relates to a method for synthesis of oligonucleotides on a solid support. The support system comprises a stable disiloxyl linkage providing high nucleoside loadings to the support and the method allows convenient non-laborious oligomer synthesis.
    Type: Grant
    Filed: August 2, 2001
    Date of Patent: August 6, 2002
    Assignee: Quiatech AB
    Inventors: Marek Kwiatkowski, Mats Nilsson, Ulf Landegren
  • Publication number: 20020103366
    Abstract: Method for one-pot deprotection of RNA molecules.
    Type: Application
    Filed: September 21, 2001
    Publication date: August 1, 2002
    Applicant: Ribozyme Pharmaceuticals, Inc.
    Inventors: Laurent Bellon, Christopher T. Workman
  • Publication number: 20020086989
    Abstract: A photoactivatable nucleic acid derivative composition in which one or more photoreactive group(s) are bound to a natural or synthetic nucleic acid. The photoreactive groups can be bound to the nucleic acid before, during or after its formation, and can thereafter be activated in order to attach the nucleic acid to another molecule, e.g., to the surface of a solid support. Also described is a method of preparing such a composition, and a method of using such a composition to attach the nucleic acid to a another molecule, such as that provided by the surface of a substrate used to prepare a nucleic acid chip by photolithographic techniques.
    Type: Application
    Filed: February 24, 1998
    Publication date: July 4, 2002
    Inventors: PATRICK E. GUIRE, MELVIN J. SWANSON, GARY W. OPPERMAN
  • Patent number: 6414127
    Abstract: Compounds having structure (1) wherein R1 is —H a protecting group, a linker or a binding partner; and R2 and R34 are as defined in the specification. The invention also provides intermediates and methods make the structure (1) compounds, as well as methods to use the compounds as labels in diagnostic assays and to enhance binding to complementary bases.
    Type: Grant
    Filed: September 21, 1999
    Date of Patent: July 2, 2002
    Assignee: ISIS Pharmaceuticals, Inc.
    Inventors: Kuei-Ying Lin, Mark D. Matteucci
  • Patent number: 6407223
    Abstract: The process of the instant invention is drawn to the synthesis of modified P-chiral nucleotide analogues in the form of pure diastereomers possessing preselected configuration at the P-atom. Oligonucleotides prepared by the method of the invention containing P-chiral compounds have enhanced hybridization and transporting properties.
    Type: Grant
    Filed: October 14, 1999
    Date of Patent: June 18, 2002
    Assignee: Polska Akademia Nauk Cenirum Badan Molekularnych i Makromlekularnych
    Inventors: Wojciech J. Stec, Lucyna A. Woźniak, Arkadiusz Chworoś, Jaroslaw Pyzowski
  • Publication number: 20020072593
    Abstract: The present invention relates to a method of preventing modification of a synthetic oligonucleotide or oligonucleotide analog during removal of at least one &bgr;-cyanoethyl protecting group from the oligonucleotide or oligonucleotide analog. The method involves contacting the oligonucleotide or oligonucleotide analog with a basic solution having at least one acrylonitrile scavenger, such as t-butylamine, at a sufficient temperature and for a sufficient period of time to remove at least one &bgr;-cyanoethyl protecting group. The present invention also relates to a method of producing a synthetic oligonucleotide or oligonucleotide analog.
    Type: Application
    Filed: June 12, 2001
    Publication date: June 13, 2002
    Applicant: Avecia Biotechnology Inc.
    Inventor: Nanda D. Sinha
  • Patent number: 6403781
    Abstract: This invention presents novel methods for synthesizing phosphorothioate oligonucleotides, using support-bound phosphoramidites. Novel intermediates useful in the methods are also provided.
    Type: Grant
    Filed: January 8, 2001
    Date of Patent: June 11, 2002
    Assignee: ISIS Pharmaceuticals, Inc.
    Inventors: Douglas L. Cole, Vasulinga Ravikumar
  • Patent number: 6399765
    Abstract: The present invention discloses improved methods for oligonucleotide synthesis and purification. In the methods of the invention, a half-life is determined for deprotection of the 5′-OH protecting group at the 5′-terminus of an oligonucleotide post-synthesis. The half-life is used to determine an optimal reaction time for removal of the 5′-OH protecting group. The methods of the invention are amenable to the large-scale synthesis and purification of oligonucleotides.
    Type: Grant
    Filed: March 17, 1999
    Date of Patent: June 4, 2002
    Assignee: ISIS Pharmaceuticals, Inc.
    Inventors: Achim H. Krotz, Bethany M. McElroy, Anthony N. Scozzari
  • Publication number: 20020058802
    Abstract: A method of synthesizing a polynucleotide which can, for example, be used during fabrication of an array. A second nucleoside is coupled to a first nucleoside through a phosphite linkage, with the second nucleoside having a hydroxyl protecting group that is a non-carbonate protecting group. The product of the foregoing step is exposed to a composition which both oxidizes the formed phosphite to a phosphate and deprotects the protected hydroxyl of the coupled nucleoside. The method has particular application to fabricating an addressable array of polynucleotides on a substrate which carries substrate bound moieties each with a hydroxyl group.
    Type: Application
    Filed: July 27, 2001
    Publication date: May 16, 2002
    Inventors: Douglas J. Dellinger, Michael G. M. Perbost, Marvin H. Caruthers, Jason R. Betley